Baidu
map

感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2018 专家共识：亚裔美国人慢性乙肝的管理

2018-02-26 外国肝病科相关专家小组（统称） Aliment Pharmacol Ther. 2018 Feb 26.

亚裔美国人慢性乙肝

慢性乙肝病毒感染临床常见，本文主要针对亚裔美国人慢性乙肝感染的管理提出指导建议。主要建议内容包括治疗药物选择，检测，疗效监测，耐药性监测，治疗随访等。

中文标题：

2018 专家共识：亚裔美国人慢性乙肝的管理

英文标题：

An expert consensus for the management of chronic hepatitis B in Asian Americans.

发布机构：

外国肝病科相关专家小组（统称）

发布日期：

2018-02-26

简要介绍：

慢性乙肝病毒感染临床常见，本文主要针对亚裔美国人慢性乙肝感染的管理提出指导建议。主要建议内容包括治疗药物选择，检测，疗效监测，耐药性监测，治疗随访等。

 

拓展指南：与乙肝相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 专家共识：亚裔美国人慢性乙肝的管理)] GetToolGuiderByIdResponse(projectId=1, id=89d781c001562eeb, title=2018 专家共识：亚裔美国人慢性乙肝的管理, enTitle=An expert consensus for the management of chronic hepatitis B in Asian Americans., guiderFrom=Aliment Pharmacol Ther. 2018 Feb 26., authorId=null, author=, summary=慢性乙肝病毒感染临床常见，本文主要针对亚裔美国人慢性乙肝感染的管理提出指导建议。主要建议内容包括治疗药物选择，检测，疗效监测，耐药性监测，治疗随访等。 , cover=, journalId=null, articlesId=null, associationId=687, associationName=外国肝病科相关专家小组（统称）, associationIntro=外国的关于肝病方面制定者的统称, copyright=0, guiderPublishedTime=Mon Feb 26 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>慢性乙肝病毒感染临床常见，本文主要针对亚裔美国人慢性乙肝感染的管理提出指导建议。主要建议内容包括治疗药物选择，检测，疗效监测，耐药性监测，治疗随访等。 </P> <P> </P>拓展指南：<strong>与<font color=red>乙肝</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=972d81c001523eaf" title="2017 ACP/CDC最佳实践建议：乙肝疫苗接种，筛查以及护理" target=_blank>2017 ACP/CDC最佳实践建议：乙肝疫苗接种，筛查以及护理</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=7852e1c001a66ec8" title="2017 WHO意见书：乙肝疫苗" target=_blank>2017 WHO意见书：乙肝疫苗</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=933441c001a658a2" title="2017 意见书：血液系统恶性肿瘤以及接受造血干细胞移植患者乙肝病毒再激活的筛查，监测预防以及治疗建议" target=_blank>2017 意见书：血液系统恶性肿瘤以及接受造血干细胞移植患者乙肝病毒再激活的筛查，监测预防以及治疗建议</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=141cf1c0013192ff" title="2016 ACOG委员会意见：妇产科医师乙肝，丙肝和艾滋病毒感染（No.655）" target=_blank>2016 ACOG委员会意见：妇产科医师乙肝，丙肝和艾滋病毒感染（No.655）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=796871c001221604" title="2015 AGA 免疫抑制治疗中乙肝病毒再激活防治指南" target=_blank>2015 AGA 免疫抑制治疗中乙肝病毒再激活防治指南</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E4%B9%99%E8%82%9D" target=_blank>有关乙肝更多指南</a></ul>, tagList=[TagDto(tagId=70872, tagName=亚裔美国人), TagDto(tagId=601, tagName=慢性乙肝)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6812, appHits=488, showAppHits=7, pcHits=4354, showPcHits=2640, likes=106, shares=4, comments=5, approvalStatus=1, publishedTime=Thu Mar 01 18:10:44 CST 2018, publishedTimeString=2018-02-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Mar 01 18:10:44 CST 2018, updatedBy=null, updatedName=null, updatedTime=Mon Jan 01 13:20:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 专家共识：亚裔美国人慢性乙肝的管理)])
2018 专家共识：亚裔美国人慢性乙肝的管理
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1213336, encodeId=bafa12133365d, content=*** 水积分的吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06cb5718776, createdName=ms7000000374177171, createdTime=Fri Apr 22 02:24:22 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292128, encodeId=cee82921283a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:45:01 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292072, encodeId=92fa2920e24d, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=557b2280424, createdName=苦苦的挣扎, createdTime=Thu Mar 01 20:02:04 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292065, encodeId=b8d42920656d, content=慢性乙肝病毒感染临床常见.本文主要针对亚裔美国人慢性乙肝感染的管理提出指导建议.主要建议内容包括治疗药物选择.检测.疗效监测.耐药性监测.治疗随访等., beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Mar 01 19:34:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292058, encodeId=41bb292058fd, content=学习学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Thu Mar 01 19:31:27 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
    2022-04-22 ms7000000374177171

    *** 水积分的吗？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1213336, encodeId=bafa12133365d, content=*** 水积分的吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06cb5718776, createdName=ms7000000374177171, createdTime=Fri Apr 22 02:24:22 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292128, encodeId=cee82921283a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:45:01 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292072, encodeId=92fa2920e24d, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=557b2280424, createdName=苦苦的挣扎, createdTime=Thu Mar 01 20:02:04 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292065, encodeId=b8d42920656d, content=慢性乙肝病毒感染临床常见.本文主要针对亚裔美国人慢性乙肝感染的管理提出指导建议.主要建议内容包括治疗药物选择.检测.疗效监测.耐药性监测.治疗随访等., beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Mar 01 19:34:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292058, encodeId=41bb292058fd, content=学习学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Thu Mar 01 19:31:27 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
    2018-03-02 121832a9m88暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1213336, encodeId=bafa12133365d, content=*** 水积分的吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06cb5718776, createdName=ms7000000374177171, createdTime=Fri Apr 22 02:24:22 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292128, encodeId=cee82921283a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:45:01 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292072, encodeId=92fa2920e24d, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=557b2280424, createdName=苦苦的挣扎, createdTime=Thu Mar 01 20:02:04 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292065, encodeId=b8d42920656d, content=慢性乙肝病毒感染临床常见.本文主要针对亚裔美国人慢性乙肝感染的管理提出指导建议.主要建议内容包括治疗药物选择.检测.疗效监测.耐药性监测.治疗随访等., beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Mar 01 19:34:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292058, encodeId=41bb292058fd, content=学习学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Thu Mar 01 19:31:27 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
    2018-03-01 苦苦的挣扎

    学习到了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1213336, encodeId=bafa12133365d, content=*** 水积分的吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06cb5718776, createdName=ms7000000374177171, createdTime=Fri Apr 22 02:24:22 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292128, encodeId=cee82921283a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:45:01 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292072, encodeId=92fa2920e24d, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=557b2280424, createdName=苦苦的挣扎, createdTime=Thu Mar 01 20:02:04 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292065, encodeId=b8d42920656d, content=慢性乙肝病毒感染临床常见.本文主要针对亚裔美国人慢性乙肝感染的管理提出指导建议.主要建议内容包括治疗药物选择.检测.疗效监测.耐药性监测.治疗随访等., beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Mar 01 19:34:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292058, encodeId=41bb292058fd, content=学习学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Thu Mar 01 19:31:27 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
    2018-03-01 有备才能无患

    慢性乙肝病毒感染临床常见.本文主要针对亚裔美国人慢性乙肝感染的管理提出指导建议.主要建议内容包括治疗药物选择.检测.疗效监测.耐药性监测.治疗随访等.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1213336, encodeId=bafa12133365d, content=*** 水积分的吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06cb5718776, createdName=ms7000000374177171, createdTime=Fri Apr 22 02:24:22 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292128, encodeId=cee82921283a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:45:01 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292072, encodeId=92fa2920e24d, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=557b2280424, createdName=苦苦的挣扎, createdTime=Thu Mar 01 20:02:04 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292065, encodeId=b8d42920656d, content=慢性乙肝病毒感染临床常见.本文主要针对亚裔美国人慢性乙肝感染的管理提出指导建议.主要建议内容包括治疗药物选择.检测.疗效监测.耐药性监测.治疗随访等., beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Mar 01 19:34:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292058, encodeId=41bb292058fd, content=学习学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Thu Mar 01 19:31:27 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
    2018-03-01 changjiu

    学习学习谢谢

    0

Baidu
map
Baidu
map
Baidu
map